Evidence map›Paper›PMID 39578342›Full record

ArticleJournal of fluorescence2025

Preliminary Development of DNA Aptamer Quantum Dot-Based Competitive Lateral Flow Assays for Saxitoxin and Tetrodotoxin.

John G Bruno

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

John G BrunoNanohmics Inc., 6201 E. Oltorf Street, Suite 400, Austin, TX, 78741, USA. jbruno@nanohmics.com.

Funding

U.S. Department of Homeland Security 70RWMD23C00000005
6 · The paper itself

Abstract

Initial proof-of-concept development of competitive lateral flow (LF) test strips involving red quantum dots (Qdots) is demonstrated with visible confirmation of the competitive displacement of Qdot-protein-saxitoxin (Stx) and -tetrodotoxin (Ttx) conjugates over 15 min. The measured limits of detection (LODs) for the best versions of the assays were in the 1-2 µg range when a bovine serum albumin (BSA)-Stx or -Ttx conjugate was used as the analyte for safety reasons and NIH ImageJ image analysis was applied. However, when one assumes that only one of the primary amines in BSA labeled with Stx or Ttx is needed as the "epitope" for capture and calculates the weight of the toxin adducts on an equal mole basis to that of 1 µg of toxin-BSA conjugate, the LODs are as low as 4.5 ng of toxin. No cross-reactivity was seen for these prototype test strips when BSA-Stx and BSA-Ttx were switched as analytes at or near their respective LODs which is in agreement with published specificity and affinity studies for these aptamers in the literature.

Indexed as

Aptamers, NucleotideQuantum DotsSaxitoxinTetrodotoxinAnimalsCattleLimit of DetectionSerum Albumin, BovineAptamers, NucleotideSaxitoxinSerum Albumin, BovineTetrodotoxinAptamerCompetitiveLateral flowQuantum dotSaxitoxinTetrodotoxin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.